Amiens rein remplissage · Amiens_rein_remplissage Keywords Created Date: 20160401155701Z ...
42
!"#$#"%&'( *+,-"./(0 1#20%32.%-0 3#$%+24( 567%.24 5(0"% 8-0$-" 9"#.(%4 : !"20+(
Transcript of Amiens rein remplissage · Amiens_rein_remplissage Keywords Created Date: 20160401155701Z ...
!"#$#"%&'()!"#$#"%&'()*+,-"./(0!"#$#"%&'()!"#$#"%&'()*+,-"./(0*+,-"./(01#20%32.%-0)3#$%+24(1#20%32.%-0)3#$%+24(567%.24)1#20%32.%-0)3#$%+24(1#20%32.%-0)3#$%+24(1#20%32.%-0)3#$%+24(567%.24)5(0"%)1#20%32.%-0)3#$%+24(1#20%32.%-0)3#$%+24(1#20%32.%-0)3#$%+24(
5(0"%)8-0$-"567%.24)567%.24)5(0"%)9"#.(%4
5(0"%)5(0"%)9"#.(%49"#.(%49"#.(%4:
5(0"%)5(0"%)8-0$-"8-0$-"5(0"%)5(0"%)5(0"%)5(0"%)9"#.(%49"#.(%4:!"20+(
!"#$%&'()*%+,-(;#<%-0<)(0$-.,#4%24(<./0&()'+1(*"1'1'(-
!2,'""()/3)/%4'1) #,*/',53(!67891(+"'9+!:+%&'(!6789;%&'(!="-'>4()$()42)3%+"-+%"+'42.%-0
:;#<%-0<)(0$-.,#4%24(<:./0&(:!<'"#9"'1%)",+=3'+(::=(+1")>,"9#9+"1*'#1(3*")::
!?'3*0"()9"&91'53(!@%,4"9*81'9+) A#,1,49-'"&())8(81'/("!!=-0'<)?2<+'42%"(
;#<%-0<).'>'42%"(<-><."'+.%?(<
" ?BC
1#."-+-0."64().'>'4-:/4-3#"'42%"(
@#<#&'%4%>"()<DAB@
E3(-E3(- 94F(#1'G94F(#1'GH
82%0.(0%"82%0.(0%" 4()4()4()$#>%.$#>%. <20/'%0<20/'%0 "#024
C04D +2"$%2+ -'.7'.
E-0)<%/0%F%+20.
I"1I"1 #(#( 53(53( J,J, &,*#$(&,*#$(H
!4'%$<!4'%$<
*(7<%< *(7<%<
IGG(#1" 9G)K,-'+(L)M,++'19-L),+/)B3*9"(&'/(9+):#31()?(#*(,"("'+)@(+,- B3+#1'9+ !+/3#(/ 47)@,/'9#9+1*,"1 :=(+1"
!"#$%&'()*+*,*-.(GHHI B-4'3()JJGKGIGL:GIMN
IGG(#1" 9G)K,-'+(L)M,++'19-L),+/)
% of contrast inducednephropathy
N,")53()4%+%G'53(O# OFF(.<)(P720<%-0
# OFF(.<)<-4'.#
!?%-'>*,+#()(+)PQ)
5#3-$%4'.%-0
Q$R3()S! 7"(<<%-0)%0.("<.%.%(44(T
5D7-P#3%(
"N*(""'9+)>('+(3"()R#9+=("1'9+S
" D9+"9&&,1'9+)1343-,'*()(+)PQ
! $')@!U)(.)$()42)+,2"/()<-$#(
T()*(&8-'"",=(8(31
!-()?K@O
U),U),VU), 1V1V1VV'-)3+)*'"53()W)-,)*("1*'#1'9+)
N3-&9+,*7 931#9&(" ,+/)8$7"'9-9='# >,*',4-(")9+)?X
?',-7"'"L)Y GN GI NVNL
N)W/ XY)W/
M9'+" /()*(&8-'"",=(
ZM9'+" /()/',-7"(O
M(#,+'"&(")M(#,+'"&(")$%&9/7+,&'53(")(1)-("'9+(-")
!""#$#%&'!$&#$()*#
+""#$#%&!$&#$()*#
Jv = Kf [(Pcapillary-PBowman) - "(! capillary-! Bowman)]
= Kf [(DP) - (D!)]
Pression de filtration !si
?%4'1)/()G'-1*,1'9+)=-9&%*3-,'*(
#Ponc capillaireVC AAVD AE#P Bowman
[78()/()"9-31%)(+)#,3"(
!N*(""'9+)/()G'-1*,1'9+
#7"(<<%-0)-0+-.%&'(
B2<-+-0<."%+.%-0)Z2FF
D9--9\/(")$78(*V9+#91'53("
D$,*=()#$-9*%()(;#(""'>(
678(*>'"#9"'1%)",+=3'+( D9--9\/(")"7+1$%1'53("
!D9+"9&&,1'9+)1343-,'*()(+)PQ
!1#2><-"7.%-0).'>'42%"()$(<)32+"-3-4#+'4(<)F%4."#(<
D9--9\/(")"7+1$%1'53("
678(*>'"#9"'1%)3*'+,'*()
!7"(<<%-0)%0.("<.%.%(44(
Hydroxyethylstarch and osmotic-nephrosis-like lesionsin kidney transplantation.
Legendre C, et al. Lancet. 1993 Jul 24;342(8865):248-9.
51 transplantationsBefore HES use
1990
39 transplantationsAfter HES 200/0.6 use
1992
Osmotic like lesions 14% 81%
3 month creatinine 100±83 !mol/l 145±71 !mol/l
1991start of HES use
in France
]^)"13/'("M(/',+)+3&4(*)9G)8,1'(+1")Z)Q])R*,+=()_`)19)a`SM(/',+)G9--9b)38Z)_Q)$93*")R*,+=()̀ c])19)_dd)$93*"S
"#$%&'()* +#+),-$-+.'( /)0()* ,-$-+.'( /
K%*3&)e 8$7"'9 f @'+=(*)-,#1,1( @'+=(*),#%1,1(\)\1Z]E !1O*OE^]* [42<324D.(1 ^<-F'0$%0(1
E2_)33-4A4 G`I GJN GJG GIN GI`
D-L)&&9-A- _]d _`g __Q ag _QX
92_)33-4A4 N GVI GVH N MV`
a_)33-4A4 N I `VI ` I
8/_)33-4A4 N N N GV` G
T,#1,1(L)&&9-A- VV Qg Qg VV VV
:#%1,1(L)&&9-A- VV VV VV QX Qd
M,-,1(L)&&9-A- VV VV VV VV ]
C-3#9+,1(L)&&9-A- VV VV VV Qh VV
C<3-_)3C<3A4 JNb M`J MYH MH` JNH
N*9/3'1")/()*(&8-'"",=()>,"#3-,'*(
D*'"1,--9\/("
!"919+'53("
! *#"'3)[,D<%-4-/%&'()
! 1%0/(" ;2+.2.(AZ+#.2.(
678(*19+'53("
E294) Jc
`c
YV`c
D9--9\/("
i,13*(-"
! Z4>'3%0(
K7+1$%1'53("
! @(P."20<
! U#42.%0(<
! 5D$"-PD#.,D423%$-0<
/,(0(1$23"*+ !4-%+ 1$23"*+ 5678799:777.(;<<=>
Z$d'<.($)C1
NV`M)eNVJYNV`M)eNVJY:NV`M)eNVJY:NVY`f_)[gNVNNG11=) Yb)SGNT IH)SLVJT NV`M)eNVJJNV`M)eNVJJNV`M)eNVJJ:NV`M)eNVJJNV`M)eNVJJ:NVbGf_)[gNVNNI
Z$d'<.($)C1
@,+/9&'"%()(+)#-3"1(*L)/934-(),>(3=-()(1)/934-()#*9"")9>(*!4'%$ Z)?<)!4'%$ \)7-'").-'.(<)4(<)%0$%+2.%-0<)$h'0)+"%<.244-i$(Z:\:Z:\)-')\:Z:\:Z)7(0$20.)Mb)<(32%0(<)2').-.24$[2<)$()+24+'4)$h(FF(+.%F)7-<<%>4(
23GG(*(/ "9-31'9+j 1%0/(")2+(.2.( S[42<324D.(12
D*'10*()8*'+#'8,-)/()F3=(&(+1j)Za^
d)"(*>'#("L)X)&9'"L)QQ^Q)8,1'(+1"0/?/>(5@;A(B#C(56D9;7E;FG8;6@;:;@
H4"3I*&' 4C(%+>(J+"- 0(/,()*#(K4L$&*+ =8(;F;=M;F9;.(5@;9
K9/'3&)4'#,*49+,1()'+)1$()8*(>(+1'9+)9G)#,*/',#)"3*=(*7V,""9#',1(/),#31()k'/+(7)'+F3*7j),)"7"1(&,1'#)*(>'(b ,+/)&(1,V,+,-7"'"=%( (.)24V)9"%.%+24 92"()MNGI_)GbK`GY
!2?-")\%+ !2?-")E*
Etsijemettaisplusdesel?
## ;()"(374%<<2/()0h(<.)72<)&'()>#0#F%&'()7-'")4()"(%0$ \#0#F%+(A"%<&'()j)#?24'(")XXX
## =-'<)4(<)+-44-i$(<)<D0.,#.%&'(<)<-0.)7"->2>4(3(0.)=-'<)4(<)+-44-i$(<)<D0.,#.%&'(<)<-0.)7"->2>4(3(0.)=-'<)4(<)+-44-i$(<)<D0.,#.%&'(<)<-0.)7"->2>4(3(0.)0#7,"-.-P%&'(<
$ ]0()24.("02.%?()(P%<.()4(<)+"%<.244-i$(<)%<-.-0%&'(<k
## ;2)3(%44('"()+,2"/()+,4-"#()7-'")4()"(%0)$ Z)$#.("3%0(")+,(l)4(<)72.%(0.<)/"2?(<
